ESC Premium Access

Great Debate: is revascularisation primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy? – discussion.

Presentation

2 more presentations in this session

Revascularisation is primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy: pro.

Speaker: Doctor R. Al-Lamee (London, GB)

Thumbnail

Revascularisation is primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy: con.

Speaker: Doctor D. Holmes (Rochester, US)

Thumbnail

Access the full session

Great Debate: is revascularisation primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy?

Speakers: Doctor R. Al-Lamee, Doctor D. Holmes
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Essential update on Multi-Modality Imaging: best practices to diagnose ischaemia in chronic coronary syndromes.

27 August 2021

ESC Premium Access

Colchicine in Acute Myocardial Infarction

27 August 2021

ESC Premium Access

Refining dual antithrombotic treatment in patients with chronic coronary syndrome

27 August 2021

This platform is supported by

logo Novo Nordisk